SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : The New QLogic (ANCR)
QLGC 16.070.0%Aug 24 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: doc who wrote (21111)3/17/1999 9:07:00 AM
From: Roy Sardina  Read Replies (2) of 29386
 
yes.

When ANCR was a buck a share we thought it could have been bought (or at least controlling interest) for less than $50M.

None of my statements is contradictory, the shares were 1-1/8; there were fewer of them than there is now; there was no poison pill; and the s holders did have the right to buy (re: issue) more at that price. That single fact is what lead us not to accumulate shares, the shear fact that they could be heavily diluted. All these facts were true at the beginning of October.

Roy

----------------- begin forward mail -----------------

roy,
you made the statement "ancr could be bought for under $50 mil" on 30 oct. 98. the
chart i've included clearly shows ancr in the $1.75 range at that time. one week later
it was over $2 and a month later it was close to $4.
exchange2000.com
from the 3rd quarterly report ancr had close to 13mil shares.
the poison pill was announced on 3 november 98.

<<"The lawyers and bankers looked at the ANCR filings and determined that the
investors ability to continue to issue shares made a significant transaction almost
impossible. So we canned the idea and moved on".

after all your contradicting statements.
do you still stand by your statement that ancr could have been bought for under $50
mil?
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext